Intranasal GDNF for Parkinson's Disease: Next steps in preclinical development

被引：0
|
作者：
Waszczak, Barbara Lee [1 ]
Wachtman, Lynn [2 ]
Newsome, Ginnifer C. [2 ]
Aly, Amirah [1 ]
Silva, Nilsa [2 ]
Westmoreland, Susan [2 ]
Rowlett, James [2 ]
Migliore, Mattia M. [3 ]
机构：
[1] Northeastern Univ, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, New England Primate Res Ctr, Southborough, MA 01772 USA
[3] Massachusetts Coll Pharm & Hlth Sci, Boston, MA USA
来源：
FASEB JOURNAL | 2013年 / 27卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
1177.10
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Thiazolidinediones under preclinical and early clinical development for the treatment of Parkinson's disease
    Carta, Anna R.
    Simuni, Tanya
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2015, 24 (02) : 219 - 227
  • [32] GDNF-based cell therapy in Parkinson's Disease
    Lopez-Barneo, J.
    HUMAN GENE THERAPY, 2013, 24 (12) : A23 - A23
  • [33] What next in Parkinson's disease?
    不详
    LANCET, 2024, 403 (10423): : 219 - 219
  • [34] Gene transfer techniques for the delivery of GDNF in Parkinson's disease
    Ridet, JL
    Déglon, N
    Aebischer, P
    NEURAL TRANSPLANTATION IN NEURODEGENERATIVE DISEASE: CURRENT STATUS AND NEW DIRECTIONS, 2000, 231 : 202 - 215
  • [35] Neurotoxins as Preclinical Models for Parkinson's Disease
    Segura-Aguilar, Juan
    NEUROTOXICITY RESEARCH, 2018, 34 (04) : 870 - 877
  • [36] Neurotoxins as Preclinical Models for Parkinson’s Disease
    Juan Segura-Aguilar
    Neurotoxicity Research, 2018, 34 : 870 - 877
  • [37] Pathogenesis and preclinical course of Parkinson's disease
    Foley, P
    Riederer, P
    JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT, 1999, (56): : 31 - 74
  • [38] Constipation - A preclinical marker of Parkinson's disease
    Rana, M. A.
    Rana, A. Q.
    Mujawaz, Y.
    MOVEMENT DISORDERS, 2013, 28 : S308 - S309
  • [39] Aminochrome as preclinical model for Parkinson's disease
    Segura-Aguilar, Juan
    ONCOTARGET, 2017, 8 (28) : 45036 - 45037
  • [40] Mechanistic Insight from Preclinical Models of Parkinson's Disease Could Help Redirect Clinical Trial Efforts in GDNF Therapy
    Delgado-Minjares, Karen M.
    Martinez-Fong, Daniel
    Martinez-Davila, Irma A.
    Banuelos, Cecilia
    Gutierrez-Castillo, M. E.
    Blanco-Alvarez, Victor Manuel
    Cardenas-Aguayo, Maria-del-Carmen
    Luna-Munoz, Jose
    Pacheco-Herrero, Mar
    Soto-Rojas, Luis O.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (21)
12345